RWS of Paclitaxel Liposome Combined With Anti-HER-2 Monoclonal Antibody
Clinical trial NCT06481553 · UNKNOWN
Trial details
- NCT number
- NCT06481553
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2023-02-01
- Primary completion
- 2024-06-30
- Enrollment
- 480
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.